Skip to main content

Alnylam Pharmaceuticals is responsible for the funding and content of this website. The site is intended for the general public in Europe, Middle East and Africa for disease awareness purposes only. Nothing on the site constitutes individual medical advice. Individuals are advised to consult their physician or other appropriate HCP. PH1-CEMEA-00034 April 2021

Living with PH1 Homepage
  • ABOUT PH1
  • MANAGEMENT
  • LIVING WITH PH1
  • SUPPORT
  • BEHANDLUNGS-ZENTREN
  • PARENTS & CAREGIVERS

Site Map

Home About PH1 Management Living with PH1 Support Parents & Caregivers
Privacy Policy Legal Notice Contact Us
container links
Links-section mt-65 mb-80 mob-mb-65

You are now leaving LivingWithPH1.eu

Links to all outside sites are provided as a reference for our visitors. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Visit Site Back to Homepage

Could it be Primary Hyperoxaluria Type 1 (PH1)?

Take this short survey to find out if you should be tested for PH1.

Get started

Alnylam Pharmaceuticals Logo

  • HOME
  • ABOUT PH1
  • MANAGEMENT
  • LIVING WITH PH1
  • SUPPORT
  • BEHANDLUNG-SZENTREN
  • PARENTS & CAREGIVERS

LivingWithPH1 is a trademark of Alnylam Pharmaceuticals, Inc.
©2021 Developed and produced by Alnylam Switzerland GmbH. All rights reserved.

  • Privacy Policy
  • Legal Notice
  • Contact Us
  • Site Map
  • Impressum
PH1-CEMEA-00034   April 2021